{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T07:34:02Z","timestamp":1778744042170,"version":"3.51.4"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>Cerebrovascular injury associated with COVID-19 has been recognized, but the mechanisms remain uncertain. Acute respiratory distress syndrome (ARDS) is a severe pulmonary injury, which is associated with both ischemic and hemorrhagic stroke. It remains unclear if cerebrovascular injuries associated with severe COVID-19 are unique to COVID-19 or a consequence of severe respiratory disease or its treatment. The frequency and patterns of cerebrovascular injury on brain MRI were compared among patients with COVID-19 ARDS and non-COVID-19 ARDS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>A case-control study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>A tertiary academic hospital system<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>Adult patients (&gt;18 yr) with COVID-19 ARDS (March 2020 to July 2021) and non-COVID-19 ARDS (January 2010-October 2018) who underwent brain MRI during their index hospitalization.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTIONS:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>Cerebrovascular injury on MRI included cerebral ischemia (ischemic infarct or hypoxic ischemic brain injury) and intracranial hemorrhage (intraparenchymal, subarachnoid, or subdural, and cerebral microbleed [CMB]).<\/jats:p>\n            <jats:p>Twenty-six patients with COVID-19 ARDS and sixty-six patients with non-COVID ARDS underwent brain MRI during the index hospitalization, resulting in 23 age- and sex-matched pairs. The frequency of overall cerebrovascular injury (57% vs 61%), cerebral ischemia (35% vs 43%), intracranial hemorrhage (43% vs 48%), and CMB (52% vs 41%) between COVID-19 ARDS and non-COVID-19 ARDS patients was similar (all <jats:italic toggle=\"yes\">p<\/jats:italic> values &gt;0.05). However, four of 26 patients (15%) with COVID-19 and no patients with non-COVID-19 ARDS had disseminated leukoencephalopathy with underlying CMBs, an imaging pattern that has previously been reported in patients with COVID-19.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>In a case-control study of selected ARDS patients with brain MRI, the frequencies of ischemic and hemorrhagic cerebrovascular injuries were similar between COVID-19 versus non-COVID-19 ARDS patients. However, the MRI pattern of disseminated hemorrhagic leukoencephalopathy was unique to the COVID-19 ARDS patients in this cohort.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ccm.0000000000005658","type":"journal-article","created":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T15:00:33Z","timestamp":1662994833000},"page":"1638-1643","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["MRI of Cerebrovascular Injury Associated With COVID-19 and Non-COVID-19 Acute Respiratory Distress Syndrome: A Matched Case-Control Study"],"prefix":"10.1097","volume":"50","author":[{"given":"Aaron","family":"Shoskes","sequence":"first","affiliation":[{"name":"Department of Neurology, Neurological Institute, Cleveland Clinic, Cleveland, OH."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merry","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Neurological Institute, Cleveland Clinic, Cleveland, OH."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aron","family":"Gedansky","sequence":"additional","affiliation":[{"name":"Department of Neurology, Neurological Institute, Cleveland Clinic, Cleveland, OH."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Hassett","sequence":"additional","affiliation":[{"name":"Cerebrovascular Center, Department of Neurology, Neurological Institute, Cleveland Clinic, Cleveland, OH."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Blake","family":"Buletko","sequence":"additional","affiliation":[{"name":"Cerebrovascular Center, Department of Neurology, Neurological Institute, Cleveland Clinic, Cleveland, OH."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhijit","family":"Duggal","sequence":"additional","affiliation":[{"name":"Department of Critical Care, Respiratory Institute, Cleveland Clinic, Cleveland, OH."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Uchino","sequence":"additional","affiliation":[{"name":"Cerebrovascular Center, Department of Neurology, Neurological Institute, Cleveland Clinic, Cleveland, OH."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Min","family":"Cho","sequence":"additional","affiliation":[{"name":"Division of Neuroscience Critical Care, Division of Cardiac Surgery, Departments of Neurology, Cardiac Surgery, Neurosurgery, Anesthesiology, and Critical Care Medicine, Johns Hopkins University, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,9,12]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"e2112131","DOI":"10.1001\/jamanetworkopen.2021.12131","article-title":"Global incidence of neurological manifestations among patients hospitalized with COVID-19-a report for the GCS-NeuroCOVID consortium and the ENERGY consortium.","volume":"4","author":"Chou","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"e1868","DOI":"10.1212\/WNL.0000000000010112","article-title":"Neurologic and neuroimaging findings in patients with COVID-19: A retrospective multicenter study.","volume":"95","author":"Kremer","year":"2020","journal-title":"Neurology"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1161\/STROKEAHA.120.030940","article-title":"Cerebral microbleeds and leukoencephalopathy in critically ill patients with COVID-19.","volume":"51","author":"Agarwal","year":"2020","journal-title":"Stroke"},{"key":"R4-20250502","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-020-02911-9","article-title":"Acute respiratory failure in COVID-19: Is it \u201ctypical\u201d ARDS?","volume":"24","author":"Li","year":"2020","journal-title":"Crit Care"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s12028-021-01309-x","article-title":"Pathophysiology of brain injury and neurological outcome in acute respiratory distress syndrome: A scoping review of preclinical to clinical studies.","volume":"35","author":"Huang","year":"2021","journal-title":"Neurocrit Care"},{"key":"R6-20250502","first-page":"2526","article-title":"Acute respiratory distress syndrome: The Berlin Definition.","volume":"307","author":"Ranieri","year":"2012","journal-title":"JAMA"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/STROKEAHA.116.016289","article-title":"Critical illness-associated cerebral microbleeds.","volume":"48","author":"Fanou","year":"2017","journal-title":"Stroke"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"E223","DOI":"10.1148\/radiol.2020202040","article-title":"COVID-19-associated diffuse leukoencephalopathy and microhemorrhages.","volume":"297","author":"Radmanesh","year":"2020","journal-title":"Radiology"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"117517","DOI":"10.1016\/j.jns.2021.117517","article-title":"Cerebrospinal fluid in COVID-19 neurological complications: Neuroaxonal damage, anti-SARS-Cov2 antibodies but no evidence of cytokine storm.","volume":"427","author":"Garcia","year":"2021","journal-title":"J Neurol Sci"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"117308","DOI":"10.1016\/j.jns.2021.117308","article-title":"Susceptibility-weighted imaging reveals cerebral microvascular injury in severe COVID-19.","volume":"421","author":"Conklin","year":"2021","journal-title":"J Neurol Sci"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000005658","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T17:12:26Z","timestamp":1746205946000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCM.0000000000005658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,12]]},"references-count":10,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000005658","relation":{},"ISSN":["0090-3493"],"issn-type":[{"value":"0090-3493","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,12]]}}}